chrisvoncsefalvay/vaers-narrative-generation huggingface dataset:
Age: 27.0
Sex: F
Vaccine: COVID19
Symptoms: Aphthous ulcer, Herpes virus infection, Pain
Clinical narrative: I experienced a severe canker sore (herpes virus) breakout in my mouth. I normally will get one or two once every now and then (every few months or so). About 48 hours after the second dose, I woke up; I experienced a severe canker sore (herpes virus) breakout in my mouth. I normally will get one or two once every now and then (every few months or so). About 48 hours after the second dose, I woke up; it was very painful; This is a spontaneous report from a contactable consumer or other non-health care professional (patient). A 27-years-old non-pregnant female patient received bnt162b2 (PFIZER-BIONTECH COVID -19 VACCINE, formulation: solution for injection, Batch/Lot number was not reported, expiry date: unknown) via an unspecified route of administration, administered in Left arm on 25Aug2021 as dose 2, single for COVID-19 immunisation (age at Vaccination: 27-years-old) from Doctor's office/urgent care. Medical history included gastritis and jejunitis. Concomitant medications included sertraline hydrochloride (ZOLOFT); desvenlafaxine succinate monohydrate (PRISTIQ); lamotrigine (LAMICTAL). All of them were taken for an unspecified indication, start and stop date were not reported. The patient previously took azithromycin [azithromycin dihydrate] and experienced Allergy. The patient previously received bnt162b2 (PFIZER-BIONTECH COVID -19 VACCINE, formulation: solution for injection, Batch/Lot number was not reported, expiry date: unknown) on 04Aug2021 intramuscularly in Left Arm as dose 1, single, for COVID-19 immunization at Doctor's office/urgent care. The patient was not tested for covid-19 before or after vaccination, and had not received other vaccines within 4 weeks prior to the vaccination. The patient had received Zoloft, Pristiq and, Lamictal. two weeks prior to the vaccination. On 27Aug2021 the patient reported "experienced a severe canker sore (herpes virus) breakout in my mouth. I normally will get one or two once every now and then (every few months or so). About 48 hours after the second dose, I woke up with 7 in mouth. 2 on my tongue, 3 inside on my bottom lip, and 2 inside of my top lip. Over the next few days, 3 more appeared. They healed on their own but it was very painful and I could hardly eat for about 3 days. The patient had not received treatment for the events. The outcome of the events was recovering.  Lot/Batch number was not provided and will request during follow-up.
Age: 30.0
Sex: M
Vaccine: COVID19
Symptoms: Back pain, Hypoaesthesia, Muscle spasms
Clinical narrative: Back cramp/pain, subsequent arm numbness
Age: 4.0
Sex: M
Vaccine: FLU4
Symptoms: Affect lability, Cytogenetic analysis, Diagnostic procedure, Electroencephalogram normal, Enuresis
Clinical narrative: Abrupt new onset vocal tic disorder, repetitive ?stimming? behaviors, sudden new onset frequent bed wetting, sudden onset emotional liability. Child needed to be withdrawn from school due to the above symptoms.  Prompted pediatrician visit (appt date 10/18/20) and referral to neurologist ? neurology (appt date 11/18/20) referred to the following: eeg to rule out seizure (ruled out), A-dos testing to rule out autism (ruled out), extensive genetic testing to rule out genetic explanations for symptoms (ruled out), referral to Tourette?s clinic (re: new vocal tics), ongoing physical therapy, ongoing occupational therapy, behavioral therapy to manage symptoms.
Age: 4.0
Sex: M
Vaccine: FLU4
Symptoms: Loss of personal independence in daily activities, Stereotypy, Tic
Clinical narrative: Abrupt new onset vocal tic disorder, repetitive ?stimming? behaviors, sudden new onset frequent bed wetting, sudden onset emotional liability. Child needed to be withdrawn from school due to the above symptoms.  Prompted pediatrician visit (appt date 10/18/20) and referral to neurologist ? neurology (appt date 11/18/20) referred to the following: eeg to rule out seizure (ruled out), A-dos testing to rule out autism (ruled out), extensive genetic testing to rule out genetic explanations for symptoms (ruled out), referral to Tourette?s clinic (re: new vocal tics), ongoing physical therapy, ongoing occupational therapy, behavioral therapy to manage symptoms.
Age: 79.0
Sex: F
Vaccine: COVID19
Symptoms: Acquired diaphragmatic eventration, Angiogram pulmonary abnormal, Atelectasis, Barium swallow, Biopsy skin normal
Clinical narrative: Patient is an 80 year old female with a past medical history of chronic respiratory failure with hypoxia, restrictive lung disease due to paralyzed right hemidiaphragm (baseline 2 L oxygen), previous CVA with left-sided weakness, chronic MSSA infection of right THA on suppressive antibiotics, hypertension, and recent admission for possible aspiration pneumonia as well as new soft tissue/lytic bone lesion concerning for metastatic disease (biopsy inconclusive) who presented from her subacute rehab facility with increasing oxygen requirements as well as a cough with concern for pneumonia. On arrival to the ER, patient was saturating normally on her baseline O2 requirement, but did briefly become hypoxic requiring non-rebreather. CTA thorax was completed and showed no evidence of pulmonary embolus, but did note interval near complete volume loss of the right lung with complete opacification of the right mainstem bronchus, bronchus intermedius, and right upper and lower airways. Remaining aerated portions of the lungs showed findings consistent with infection or pulmonary edema and trace/small effusions present bilaterally. Patient was started on broad-spectrum antibiotics to cover for hospital-acquired, aspiration, and post-obstructive pneumonia. This included doxycycline, flagyl, and cefepime. Infectious disease and pulmonology consulted. Aggressive airway clearance regimen was initiated due to suspected mucus plugging. Bronchoscopy was performed on 9/10 which was notable for thick secretions and mucus obstructing the right mainstem bronchus. Secretions were suctioned and continued bronchopulmonary hygiene recommended. Chest X-ray performed on 9/12 to re-evaluate which demonstrated at least partial resolution of prior mucous plugging. Residual atelectasis/consolidation throughout the right middle and basilar lung fields was also noted. SLP also saw patient due to concern for aspiration risk and performed a videofluoroscopy swallow study. It was recommended she have supervision to ensure she eats and drinks at a slow rate to minimize aspiration risk. PT/OT saw patient with recommendations to return to sub-acute rehab facility. Patient's shortness of breath and cough significantly improved to the point she was felt stable for discharge back to her facility to complete her course of antibiotics for pneumonia.
Age: 79.0
Sex: F
Vaccine: COVID19
Symptoms: Blood culture negative, Bone lesion, Bronchial secretion retention, Bronchoscopy abnormal, Chest X-ray abnormal
Clinical narrative: Patient is an 80 year old female with a past medical history of chronic respiratory failure with hypoxia, restrictive lung disease due to paralyzed right hemidiaphragm (baseline 2 L oxygen), previous CVA with left-sided weakness, chronic MSSA infection of right THA on suppressive antibiotics, hypertension, and recent admission for possible aspiration pneumonia as well as new soft tissue/lytic bone lesion concerning for metastatic disease (biopsy inconclusive) who presented from her subacute rehab facility with increasing oxygen requirements as well as a cough with concern for pneumonia. On arrival to the ER, patient was saturating normally on her baseline O2 requirement, but did briefly become hypoxic requiring non-rebreather. CTA thorax was completed and showed no evidence of pulmonary embolus, but did note interval near complete volume loss of the right lung with complete opacification of the right mainstem bronchus, bronchus intermedius, and right upper and lower airways. Remaining aerated portions of the lungs showed findings consistent with infection or pulmonary edema and trace/small effusions present bilaterally. Patient was started on broad-spectrum antibiotics to cover for hospital-acquired, aspiration, and post-obstructive pneumonia. This included doxycycline, flagyl, and cefepime. Infectious disease and pulmonology consulted. Aggressive airway clearance regimen was initiated due to suspected mucus plugging. Bronchoscopy was performed on 9/10 which was notable for thick secretions and mucus obstructing the right mainstem bronchus. Secretions were suctioned and continued bronchopulmonary hygiene recommended. Chest X-ray performed on 9/12 to re-evaluate which demonstrated at least partial resolution of prior mucous plugging. Residual atelectasis/consolidation throughout the right middle and basilar lung fields was also noted. SLP also saw patient due to concern for aspiration risk and performed a videofluoroscopy swallow study. It was recommended she have supervision to ensure she eats and drinks at a slow rate to minimize aspiration risk. PT/OT saw patient with recommendations to return to sub-acute rehab facility. Patient's shortness of breath and cough significantly improved to the point she was felt stable for discharge back to her facility to complete her course of antibiotics for pneumonia.
Age: 79.0
Sex: F
Vaccine: COVID19
Symptoms: Computerised tomogram thorax abnormal, Condition aggravated, Cough, Dyspnoea, Hiatus hernia
Clinical narrative: Patient is an 80 year old female with a past medical history of chronic respiratory failure with hypoxia, restrictive lung disease due to paralyzed right hemidiaphragm (baseline 2 L oxygen), previous CVA with left-sided weakness, chronic MSSA infection of right THA on suppressive antibiotics, hypertension, and recent admission for possible aspiration pneumonia as well as new soft tissue/lytic bone lesion concerning for metastatic disease (biopsy inconclusive) who presented from her subacute rehab facility with increasing oxygen requirements as well as a cough with concern for pneumonia. On arrival to the ER, patient was saturating normally on her baseline O2 requirement, but did briefly become hypoxic requiring non-rebreather. CTA thorax was completed and showed no evidence of pulmonary embolus, but did note interval near complete volume loss of the right lung with complete opacification of the right mainstem bronchus, bronchus intermedius, and right upper and lower airways. Remaining aerated portions of the lungs showed findings consistent with infection or pulmonary edema and trace/small effusions present bilaterally. Patient was started on broad-spectrum antibiotics to cover for hospital-acquired, aspiration, and post-obstructive pneumonia. This included doxycycline, flagyl, and cefepime. Infectious disease and pulmonology consulted. Aggressive airway clearance regimen was initiated due to suspected mucus plugging. Bronchoscopy was performed on 9/10 which was notable for thick secretions and mucus obstructing the right mainstem bronchus. Secretions were suctioned and continued bronchopulmonary hygiene recommended. Chest X-ray performed on 9/12 to re-evaluate which demonstrated at least partial resolution of prior mucous plugging. Residual atelectasis/consolidation throughout the right middle and basilar lung fields was also noted. SLP also saw patient due to concern for aspiration risk and performed a videofluoroscopy swallow study. It was recommended she have supervision to ensure she eats and drinks at a slow rate to minimize aspiration risk. PT/OT saw patient with recommendations to return to sub-acute rehab facility. Patient's shortness of breath and cough significantly improved to the point she was felt stable for discharge back to her facility to complete her course of antibiotics for pneumonia.
Age: 79.0
Sex: F
Vaccine: COVID19
Symptoms: Hyperhidrosis, Hypoxia, Infection, Lung consolidation, Lung opacity
Clinical narrative: Patient is an 80 year old female with a past medical history of chronic respiratory failure with hypoxia, restrictive lung disease due to paralyzed right hemidiaphragm (baseline 2 L oxygen), previous CVA with left-sided weakness, chronic MSSA infection of right THA on suppressive antibiotics, hypertension, and recent admission for possible aspiration pneumonia as well as new soft tissue/lytic bone lesion concerning for metastatic disease (biopsy inconclusive) who presented from her subacute rehab facility with increasing oxygen requirements as well as a cough with concern for pneumonia. On arrival to the ER, patient was saturating normally on her baseline O2 requirement, but did briefly become hypoxic requiring non-rebreather. CTA thorax was completed and showed no evidence of pulmonary embolus, but did note interval near complete volume loss of the right lung with complete opacification of the right mainstem bronchus, bronchus intermedius, and right upper and lower airways. Remaining aerated portions of the lungs showed findings consistent with infection or pulmonary edema and trace/small effusions present bilaterally. Patient was started on broad-spectrum antibiotics to cover for hospital-acquired, aspiration, and post-obstructive pneumonia. This included doxycycline, flagyl, and cefepime. Infectious disease and pulmonology consulted. Aggressive airway clearance regimen was initiated due to suspected mucus plugging. Bronchoscopy was performed on 9/10 which was notable for thick secretions and mucus obstructing the right mainstem bronchus. Secretions were suctioned and continued bronchopulmonary hygiene recommended. Chest X-ray performed on 9/12 to re-evaluate which demonstrated at least partial resolution of prior mucous plugging. Residual atelectasis/consolidation throughout the right middle and basilar lung fields was also noted. SLP also saw patient due to concern for aspiration risk and performed a videofluoroscopy swallow study. It was recommended she have supervision to ensure she eats and drinks at a slow rate to minimize aspiration risk. PT/OT saw patient with recommendations to return to sub-acute rehab facility. Patient's shortness of breath and cough significantly improved to the point she was felt stable for discharge back to her facility to complete her course of antibiotics for pneumonia.
Age: 79.0
Sex: F
Vaccine: COVID19
Symptoms: Pleural effusion, Pneumonia, Pneumonia aspiration, Pulmonary hypertension, Pulmonary oedema
Clinical narrative: Patient is an 80 year old female with a past medical history of chronic respiratory failure with hypoxia, restrictive lung disease due to paralyzed right hemidiaphragm (baseline 2 L oxygen), previous CVA with left-sided weakness, chronic MSSA infection of right THA on suppressive antibiotics, hypertension, and recent admission for possible aspiration pneumonia as well as new soft tissue/lytic bone lesion concerning for metastatic disease (biopsy inconclusive) who presented from her subacute rehab facility with increasing oxygen requirements as well as a cough with concern for pneumonia. On arrival to the ER, patient was saturating normally on her baseline O2 requirement, but did briefly become hypoxic requiring non-rebreather. CTA thorax was completed and showed no evidence of pulmonary embolus, but did note interval near complete volume loss of the right lung with complete opacification of the right mainstem bronchus, bronchus intermedius, and right upper and lower airways. Remaining aerated portions of the lungs showed findings consistent with infection or pulmonary edema and trace/small effusions present bilaterally. Patient was started on broad-spectrum antibiotics to cover for hospital-acquired, aspiration, and post-obstructive pneumonia. This included doxycycline, flagyl, and cefepime. Infectious disease and pulmonology consulted. Aggressive airway clearance regimen was initiated due to suspected mucus plugging. Bronchoscopy was performed on 9/10 which was notable for thick secretions and mucus obstructing the right mainstem bronchus. Secretions were suctioned and continued bronchopulmonary hygiene recommended. Chest X-ray performed on 9/12 to re-evaluate which demonstrated at least partial resolution of prior mucous plugging. Residual atelectasis/consolidation throughout the right middle and basilar lung fields was also noted. SLP also saw patient due to concern for aspiration risk and performed a videofluoroscopy swallow study. It was recommended she have supervision to ensure she eats and drinks at a slow rate to minimize aspiration risk. PT/OT saw patient with recommendations to return to sub-acute rehab facility. Patient's shortness of breath and cough significantly improved to the point she was felt stable for discharge back to her facility to complete her course of antibiotics for pneumonia.
Age: 79.0
Sex: F
Vaccine: COVID19
Symptoms: SARS-CoV-2 test negative, Scan with contrast abnormal, X-ray
Clinical narrative: Patient is an 80 year old female with a past medical history of chronic respiratory failure with hypoxia, restrictive lung disease due to paralyzed right hemidiaphragm (baseline 2 L oxygen), previous CVA with left-sided weakness, chronic MSSA infection of right THA on suppressive antibiotics, hypertension, and recent admission for possible aspiration pneumonia as well as new soft tissue/lytic bone lesion concerning for metastatic disease (biopsy inconclusive) who presented from her subacute rehab facility with increasing oxygen requirements as well as a cough with concern for pneumonia. On arrival to the ER, patient was saturating normally on her baseline O2 requirement, but did briefly become hypoxic requiring non-rebreather. CTA thorax was completed and showed no evidence of pulmonary embolus, but did note interval near complete volume loss of the right lung with complete opacification of the right mainstem bronchus, bronchus intermedius, and right upper and lower airways. Remaining aerated portions of the lungs showed findings consistent with infection or pulmonary edema and trace/small effusions present bilaterally. Patient was started on broad-spectrum antibiotics to cover for hospital-acquired, aspiration, and post-obstructive pneumonia. This included doxycycline, flagyl, and cefepime. Infectious disease and pulmonology consulted. Aggressive airway clearance regimen was initiated due to suspected mucus plugging. Bronchoscopy was performed on 9/10 which was notable for thick secretions and mucus obstructing the right mainstem bronchus. Secretions were suctioned and continued bronchopulmonary hygiene recommended. Chest X-ray performed on 9/12 to re-evaluate which demonstrated at least partial resolution of prior mucous plugging. Residual atelectasis/consolidation throughout the right middle and basilar lung fields was also noted. SLP also saw patient due to concern for aspiration risk and performed a videofluoroscopy swallow study. It was recommended she have supervision to ensure she eats and drinks at a slow rate to minimize aspiration risk. PT/OT saw patient with recommendations to return to sub-acute rehab facility. Patient's shortness of breath and cough significantly improved to the point she was felt stable for discharge back to her facility to complete her course of antibiotics for pneumonia.
Age: 87.0
Sex: F
Vaccine: COVID19
Symptoms: Abdominal pain, Abdominal pain lower, Adenovirus test, Atelectasis, Blood lactic acid
Clinical narrative: Patient is a 88 y.o. female who presents today with episode of rectal bleeding. She woke up around 2am to use the restroom and noted bright red blood per rectum. Associated with mild left lower quadrant crampy pain. She had 2 episodes at home and then presented to the ED. While in the ED she had additional bright red bleeding with clots. This was associated with lightheadedness and syncopal episode while on the commode. A brief episode of CPR was performed due to unresponsiveness and she revived. Her vital signs stabilized. Significant lab finding included lactic acid 3.0, Hgb drop from 13 to 10. . She was resuscitated with 2 units of PRBC emergently and sent for a CTA abdomen and pelvis which showed no acute GI hemorrhage, mild inflammatory finding suspect colitis vs diverticulitis. Discussed with GI and it was advised patient transfer for evaluation of scope. Patient has had previous episode of bright red rectal bleeding, first was about 5 years ago presumed due to diverticular bleeding and was hospitalized in 2017. She had colonoscopy at that time that showed diverticulitis in sigmoid colon. No intervention needed at this time. She had a second episode of rectal bleeding about 1 year ago. She wa not hospitalized at that time. She was referred to a general surgeon at that time for EGD/colonoscopy which she declined at that time (11/2020).
Age: 87.0
Sex: F
Vaccine: COVID19
Symptoms: Bordetella test negative, COVID-19, Chest X-ray abnormal, Chlamydia test negative, Colitis
Clinical narrative: Patient is a 88 y.o. female who presents today with episode of rectal bleeding. She woke up around 2am to use the restroom and noted bright red blood per rectum. Associated with mild left lower quadrant crampy pain. She had 2 episodes at home and then presented to the ED. While in the ED she had additional bright red bleeding with clots. This was associated with lightheadedness and syncopal episode while on the commode. A brief episode of CPR was performed due to unresponsiveness and she revived. Her vital signs stabilized. Significant lab finding included lactic acid 3.0, Hgb drop from 13 to 10. . She was resuscitated with 2 units of PRBC emergently and sent for a CTA abdomen and pelvis which showed no acute GI hemorrhage, mild inflammatory finding suspect colitis vs diverticulitis. Discussed with GI and it was advised patient transfer for evaluation of scope. Patient has had previous episode of bright red rectal bleeding, first was about 5 years ago presumed due to diverticular bleeding and was hospitalized in 2017. She had colonoscopy at that time that showed diverticulitis in sigmoid colon. No intervention needed at this time. She had a second episode of rectal bleeding about 1 year ago. She wa not hospitalized at that time. She was referred to a general surgeon at that time for EGD/colonoscopy which she declined at that time (11/2020).
Age: 87.0
Sex: F
Vaccine: COVID19
Symptoms: Computerised tomogram abdomen, Computerised tomogram abdomen normal, Condition aggravated, Coronavirus test negative, Diverticulitis
Clinical narrative: Patient is a 88 y.o. female who presents today with episode of rectal bleeding. She woke up around 2am to use the restroom and noted bright red blood per rectum. Associated with mild left lower quadrant crampy pain. She had 2 episodes at home and then presented to the ED. While in the ED she had additional bright red bleeding with clots. This was associated with lightheadedness and syncopal episode while on the commode. A brief episode of CPR was performed due to unresponsiveness and she revived. Her vital signs stabilized. Significant lab finding included lactic acid 3.0, Hgb drop from 13 to 10. . She was resuscitated with 2 units of PRBC emergently and sent for a CTA abdomen and pelvis which showed no acute GI hemorrhage, mild inflammatory finding suspect colitis vs diverticulitis. Discussed with GI and it was advised patient transfer for evaluation of scope. Patient has had previous episode of bright red rectal bleeding, first was about 5 years ago presumed due to diverticular bleeding and was hospitalized in 2017. She had colonoscopy at that time that showed diverticulitis in sigmoid colon. No intervention needed at this time. She had a second episode of rectal bleeding about 1 year ago. She wa not hospitalized at that time. She was referred to a general surgeon at that time for EGD/colonoscopy which she declined at that time (11/2020).
Age: 87.0
Sex: F
Vaccine: COVID19
Symptoms: Dizziness, Enterovirus test negative, Gastrointestinal inflammation, Haemoglobin decreased, Human metapneumovirus test
Clinical narrative: Patient is a 88 y.o. female who presents today with episode of rectal bleeding. She woke up around 2am to use the restroom and noted bright red blood per rectum. Associated with mild left lower quadrant crampy pain. She had 2 episodes at home and then presented to the ED. While in the ED she had additional bright red bleeding with clots. This was associated with lightheadedness and syncopal episode while on the commode. A brief episode of CPR was performed due to unresponsiveness and she revived. Her vital signs stabilized. Significant lab finding included lactic acid 3.0, Hgb drop from 13 to 10. . She was resuscitated with 2 units of PRBC emergently and sent for a CTA abdomen and pelvis which showed no acute GI hemorrhage, mild inflammatory finding suspect colitis vs diverticulitis. Discussed with GI and it was advised patient transfer for evaluation of scope. Patient has had previous episode of bright red rectal bleeding, first was about 5 years ago presumed due to diverticular bleeding and was hospitalized in 2017. She had colonoscopy at that time that showed diverticulitis in sigmoid colon. No intervention needed at this time. She had a second episode of rectal bleeding about 1 year ago. She wa not hospitalized at that time. She was referred to a general surgeon at that time for EGD/colonoscopy which she declined at that time (11/2020).
Age: 87.0
Sex: F
Vaccine: COVID19
Symptoms: Human rhinovirus test, Influenza A virus test negative, Influenza B virus test, Influenza virus test negative, Laboratory test
Clinical narrative: Patient is a 88 y.o. female who presents today with episode of rectal bleeding. She woke up around 2am to use the restroom and noted bright red blood per rectum. Associated with mild left lower quadrant crampy pain. She had 2 episodes at home and then presented to the ED. While in the ED she had additional bright red bleeding with clots. This was associated with lightheadedness and syncopal episode while on the commode. A brief episode of CPR was performed due to unresponsiveness and she revived. Her vital signs stabilized. Significant lab finding included lactic acid 3.0, Hgb drop from 13 to 10. . She was resuscitated with 2 units of PRBC emergently and sent for a CTA abdomen and pelvis which showed no acute GI hemorrhage, mild inflammatory finding suspect colitis vs diverticulitis. Discussed with GI and it was advised patient transfer for evaluation of scope. Patient has had previous episode of bright red rectal bleeding, first was about 5 years ago presumed due to diverticular bleeding and was hospitalized in 2017. She had colonoscopy at that time that showed diverticulitis in sigmoid colon. No intervention needed at this time. She had a second episode of rectal bleeding about 1 year ago. She wa not hospitalized at that time. She was referred to a general surgeon at that time for EGD/colonoscopy which she declined at that time (11/2020).
Age: 87.0
Sex: F
Vaccine: COVID19
Symptoms: Mycoplasma test negative, Rectal haemorrhage, Respiratory syncytial virus test negative, Resuscitation, SARS-CoV-2 test positive
Clinical narrative: Patient is a 88 y.o. female who presents today with episode of rectal bleeding. She woke up around 2am to use the restroom and noted bright red blood per rectum. Associated with mild left lower quadrant crampy pain. She had 2 episodes at home and then presented to the ED. While in the ED she had additional bright red bleeding with clots. This was associated with lightheadedness and syncopal episode while on the commode. A brief episode of CPR was performed due to unresponsiveness and she revived. Her vital signs stabilized. Significant lab finding included lactic acid 3.0, Hgb drop from 13 to 10. . She was resuscitated with 2 units of PRBC emergently and sent for a CTA abdomen and pelvis which showed no acute GI hemorrhage, mild inflammatory finding suspect colitis vs diverticulitis. Discussed with GI and it was advised patient transfer for evaluation of scope. Patient has had previous episode of bright red rectal bleeding, first was about 5 years ago presumed due to diverticular bleeding and was hospitalized in 2017. She had colonoscopy at that time that showed diverticulitis in sigmoid colon. No intervention needed at this time. She had a second episode of rectal bleeding about 1 year ago. She wa not hospitalized at that time. She was referred to a general surgeon at that time for EGD/colonoscopy which she declined at that time (11/2020).
Age: 87.0
Sex: F
Vaccine: COVID19
Symptoms: Stool analysis, Syncope, Thrombosis, Transfusion, Unresponsive to stimuli
Clinical narrative: Patient is a 88 y.o. female who presents today with episode of rectal bleeding. She woke up around 2am to use the restroom and noted bright red blood per rectum. Associated with mild left lower quadrant crampy pain. She had 2 episodes at home and then presented to the ED. While in the ED she had additional bright red bleeding with clots. This was associated with lightheadedness and syncopal episode while on the commode. A brief episode of CPR was performed due to unresponsiveness and she revived. Her vital signs stabilized. Significant lab finding included lactic acid 3.0, Hgb drop from 13 to 10. . She was resuscitated with 2 units of PRBC emergently and sent for a CTA abdomen and pelvis which showed no acute GI hemorrhage, mild inflammatory finding suspect colitis vs diverticulitis. Discussed with GI and it was advised patient transfer for evaluation of scope. Patient has had previous episode of bright red rectal bleeding, first was about 5 years ago presumed due to diverticular bleeding and was hospitalized in 2017. She had colonoscopy at that time that showed diverticulitis in sigmoid colon. No intervention needed at this time. She had a second episode of rectal bleeding about 1 year ago. She wa not hospitalized at that time. She was referred to a general surgeon at that time for EGD/colonoscopy which she declined at that time (11/2020).
Age: 87.0
Sex: F
Vaccine: COVID19
Symptoms: Viral test
Clinical narrative: Patient is a 88 y.o. female who presents today with episode of rectal bleeding. She woke up around 2am to use the restroom and noted bright red blood per rectum. Associated with mild left lower quadrant crampy pain. She had 2 episodes at home and then presented to the ED. While in the ED she had additional bright red bleeding with clots. This was associated with lightheadedness and syncopal episode while on the commode. A brief episode of CPR was performed due to unresponsiveness and she revived. Her vital signs stabilized. Significant lab finding included lactic acid 3.0, Hgb drop from 13 to 10. . She was resuscitated with 2 units of PRBC emergently and sent for a CTA abdomen and pelvis which showed no acute GI hemorrhage, mild inflammatory finding suspect colitis vs diverticulitis. Discussed with GI and it was advised patient transfer for evaluation of scope. Patient has had previous episode of bright red rectal bleeding, first was about 5 years ago presumed due to diverticular bleeding and was hospitalized in 2017. She had colonoscopy at that time that showed diverticulitis in sigmoid colon. No intervention needed at this time. She had a second episode of rectal bleeding about 1 year ago. She wa not hospitalized at that time. She was referred to a general surgeon at that time for EGD/colonoscopy which she declined at that time (11/2020).
Age: 31.0
Sex: F
Vaccine: COVID19, COVID19
Symptoms: Amenorrhoea, Heavy menstrual bleeding
Clinical narrative: Missed period for 5 months.  I should?ve started April 1, but after my first dose (March 15, 2021), I didn?t have another period until August 13, 2021.   The first period was 2 days longer than normal, and twice as heavy.
Age: 73.0
Sex: M
Vaccine: COVID19
Symptoms: Angiogram pulmonary abnormal, Arteriosclerosis coronary artery, COVID-19, Cardiomegaly, Chest pain
Clinical narrative: Patient is a 74 y.o. male with past medical history of diet-controlled diabetes mellitus type 2 who presents emergency department for worsening symptoms of COVID-19.  Symptoms began a little over week ago and consist of fevers, chills, sore throat, nasal congestion, shortness of breath, productive cough, chest pain elicited by coughing, and mild nausea with vomiting.  Symptoms have slowly been worsening to the point where he is now dyspneic while at rest.  He tested positive on 9/30 and received monoclonal antibodies and 10/1. Patient was vaccinated with J and J vaccine in April.  In the emergency department he was mildly hypoxic with SpO2 currently stable on 2 L nasal cannula.  Labs are fairly unremarkable.  CTA thorax negative for PE but does show bilateral extensive bronchopneumonia with features typical of COVID infection. Hospital is admitting the patient for further evaluation and management.
Age: 73.0
Sex: M
Vaccine: COVID19
Symptoms: Chills, Dyspnoea, Dyspnoea at rest, Hypoxia, Nasal congestion
Clinical narrative: Patient is a 74 y.o. male with past medical history of diet-controlled diabetes mellitus type 2 who presents emergency department for worsening symptoms of COVID-19.  Symptoms began a little over week ago and consist of fevers, chills, sore throat, nasal congestion, shortness of breath, productive cough, chest pain elicited by coughing, and mild nausea with vomiting.  Symptoms have slowly been worsening to the point where he is now dyspneic while at rest.  He tested positive on 9/30 and received monoclonal antibodies and 10/1. Patient was vaccinated with J and J vaccine in April.  In the emergency department he was mildly hypoxic with SpO2 currently stable on 2 L nasal cannula.  Labs are fairly unremarkable.  CTA thorax negative for PE but does show bilateral extensive bronchopneumonia with features typical of COVID infection. Hospital is admitting the patient for further evaluation and management.
Age: 73.0
Sex: M
Vaccine: COVID19
Symptoms: Nausea, Pneumonia, Productive cough, Pyrexia, SARS-CoV-2 test positive
Clinical narrative: Patient is a 74 y.o. male with past medical history of diet-controlled diabetes mellitus type 2 who presents emergency department for worsening symptoms of COVID-19.  Symptoms began a little over week ago and consist of fevers, chills, sore throat, nasal congestion, shortness of breath, productive cough, chest pain elicited by coughing, and mild nausea with vomiting.  Symptoms have slowly been worsening to the point where he is now dyspneic while at rest.  He tested positive on 9/30 and received monoclonal antibodies and 10/1. Patient was vaccinated with J and J vaccine in April.  In the emergency department he was mildly hypoxic with SpO2 currently stable on 2 L nasal cannula.  Labs are fairly unremarkable.  CTA thorax negative for PE but does show bilateral extensive bronchopneumonia with features typical of COVID infection. Hospital is admitting the patient for further evaluation and management.
Age: 73.0
Sex: M
Vaccine: COVID19
Symptoms: Scan with contrast, Vomiting
Clinical narrative: Patient is a 74 y.o. male with past medical history of diet-controlled diabetes mellitus type 2 who presents emergency department for worsening symptoms of COVID-19.  Symptoms began a little over week ago and consist of fevers, chills, sore throat, nasal congestion, shortness of breath, productive cough, chest pain elicited by coughing, and mild nausea with vomiting.  Symptoms have slowly been worsening to the point where he is now dyspneic while at rest.  He tested positive on 9/30 and received monoclonal antibodies and 10/1. Patient was vaccinated with J and J vaccine in April.  In the emergency department he was mildly hypoxic with SpO2 currently stable on 2 L nasal cannula.  Labs are fairly unremarkable.  CTA thorax negative for PE but does show bilateral extensive bronchopneumonia with features typical of COVID infection. Hospital is admitting the patient for further evaluation and management.
Age: 30.0
Sex: F
Vaccine: COVID19
Symptoms: Interchange of vaccine products
Clinical narrative: received their 1st dose of the COMIRNATY vaccine dated 11Aug2021 and was inadvertently administered with with the Moderna vaccine today for her 2nd dose; This is a spontaneous report from a contactable Nurse. A 30-year-old female patient received first dose of bnt162b2 (COMIRNATY, Solution injection, Lot number: FC3181 and Expiration date: 31Oct2021), via an intramuscular route of administration, administered in left deltoid on 11Aug2021 (at the age of 30-year-old), DOSE 1, 0.3 ML SINGLE for covid-19 immunisation and received the second dose of covid-19 vaccine mRNA (mRNA 1273; MODERNA COVID-19 VACCINE; Batch/Lot number: 027C21A and Expiration date: 26Oct2021), via an intramuscular route of administration, administered in right deltoid on 03Sep2021 (at the age of 30-year-old), as DOSE 2, 0.5 ML SINGLE for covid-19 immunisation. The patient medical history and concomitant medications were not reported. The reporter confirmed she was calling regarding the Pfizer COVID vaccine. The reporter had a question. She stated her facility was doing injections, and they had a patient who had received their first Pfizer COVID vaccine on 11Aug2021. The patient came in today 03Sep2021 for the second dose and however, instead of receiving Pfizer, the patient inadvertently administered with Moderna. The reporter was calling to see what the side effects were and if they needed to repeat the patient's second dose. There was no Investigation Assessment provided. This report was not related to a study or programme.  The lot number for BNT162B2 was not provided and will be requested during follow up.  Follow-up (03Sep2021): This is a follow-up spontaneous report from a contactable Nurse. This Nurse reported for a patient included: added the dose, route of administration, anatomical location of vaccination, lot number and expiration date for both COMIRNATY and MODERNA vaccine  No further details were provided or obtained.
Sex: F
Vaccine: COVID19
Symptoms: Anxiety, Blood test, Dizziness, Ear infection, Ear pain
Clinical narrative: brain fog; dizziness; allergies; anxiety; vertigo; ear pain; ear infection; This is a spontaneous report from a contactable consumer or other non health care professional. A 21-year-old female patient received first dose of BNT162B2 (PFIZER-BIONTECH COVID-19 mRNA VACCINE, formulation: solution for injection, lot number was not reported, expiration date was not reported), via an unspecified route of administration on 21Mar2021 as dose 1, single for covid-19 immunization. The patient medical history included anxiety, allergies. The patient concomitant medications were not reported. It was reported that, patient is 21/F. Got rm. first vaccine on 21Mar had severe brain fog and dizziness after the first week or so of getting the vaccine. Went to two doctors and they said she was having allergies/anxiety. Got blood drawn everything came back normal. Symptoms started to subside, although she was still having small bouts of vertigo. By this point was dealing with ear pain/fullness but dizziness was mainly gone. Went to two more doctors because she believed she had an ear infection, was given a 5 day course of Prednisone, which to be honest her symptoms were already subsiding so she didn't think much about how well the prednisone worked. The patient underwent lab tests and procedures which included blood work (blood test): normal (everything came back normal) on an unspecified date. The adverse events resulted in physician office visit. Therapeutic measures were taken as a result of all events. The outcome of the events was unknown.  The lot number for the vaccine, [BNT162B2], was not provided and will be requested during follow up.
Sex: F
Vaccine: COVID19
Symptoms: Feeling abnormal, Hypersensitivity, Vertigo
Clinical narrative: brain fog; dizziness; allergies; anxiety; vertigo; ear pain; ear infection; This is a spontaneous report from a contactable consumer or other non health care professional. A 21-year-old female patient received first dose of BNT162B2 (PFIZER-BIONTECH COVID-19 mRNA VACCINE, formulation: solution for injection, lot number was not reported, expiration date was not reported), via an unspecified route of administration on 21Mar2021 as dose 1, single for covid-19 immunization. The patient medical history included anxiety, allergies. The patient concomitant medications were not reported. It was reported that, patient is 21/F. Got rm. first vaccine on 21Mar had severe brain fog and dizziness after the first week or so of getting the vaccine. Went to two doctors and they said she was having allergies/anxiety. Got blood drawn everything came back normal. Symptoms started to subside, although she was still having small bouts of vertigo. By this point was dealing with ear pain/fullness but dizziness was mainly gone. Went to two more doctors because she believed she had an ear infection, was given a 5 day course of Prednisone, which to be honest her symptoms were already subsiding so she didn't think much about how well the prednisone worked. The patient underwent lab tests and procedures which included blood work (blood test): normal (everything came back normal) on an unspecified date. The adverse events resulted in physician office visit. Therapeutic measures were taken as a result of all events. The outcome of the events was unknown.  The lot number for the vaccine, [BNT162B2], was not provided and will be requested during follow up.
Age: 84.0
Sex: M
Vaccine: COVID19
Symptoms: Feeling abnormal, Pruritus, Psoriasis, Urticaria
Clinical narrative: his whole entire body broke out with welts/They were like red welts all over his whole body; the dermatologist said it was psoriasis; all over itching; he was miserable; This is a spontaneous report received from a contactable consumer (patient's daughter). A 85-year-old male patient received second dose of BNT162B2 (PFIZER-BIONTECH COVID-19 VACCINE; Solution for injection; Lot number: EN6200, expiry date: unknown), via an unspecified route of administration on arm left on 18Feb2021 (age at vaccination: 84 years) as dose 2, single for COVID-19 immunization. The patient medical history was not reported. The patient Concomitant medications included Levothyroxine taken for thyroid removed (Thyroidectomy) from an unknown date. The past drug event included Glucosamine taken for Joint stuff(He might take glucosamine for joint stuff but he is in better shape than her). Additional Vaccines Administered on Same Date of the Pfizer Suspect was reported as no. Adverse events following prior vaccinations was reported as none. Family Medical History Relevant to Adverse event was reported as none.  Patient's Medical History (including any illness at time of vaccination) was reported as none. Prior Vaccinations (within 4 weeks) was reported as no.The patient previously received first dose of BNT162B2 (PFIZER-BIONTECH COVID-19 VACCINE, Solution for injection; Lot number: EL9262), dose 1 via an unspecified route of administration on left arm on 28Jan2021 (at age of 84 years) as DOSE 1, SINGLE for COVID-19 immunisation. On an unspecified date in Mar2021, the patient experienced his whole entire body broke out with welts/They were like red welts all over his whole body It was gradual, over the whole body, it was the chest, then to the legs, arms and back, the dermatologist said it was psoriasis, all over itching, to the point of torture he was miserable. It was reported that After the second dose, his whole entire body broke out with welts. They say it is psoriasis all over. It is all over itching, to the point of torture, he was miserable. They were like red welts all over his whole body and the dermatologist said it was psoriasis, and he has never has psoriasis in his life. It was gradual, over the whole body, it was the chest, then to the legs, arms and back. Because it happened back in Mar2021, she does not really remember how it all evolved. On Easter, when sitting out in the sun, all of a sudden, his legs got three times worse. That was in Apr2021 and she thinks it was the first week in Apr2021. It started in Mar2021, about a week or so after the second shot. He is still experiencing this all now but has made tremendous progress. It has taken months of treatment and research. At the beginning of Mar2021, the symptoms started then they progressed and got horrible by Apr2021. His primary care doctor did say it was the vaccine. The event broke out in welts and was itching resulted in physician office visit. The outcome of events was resolving.  Follow-up (09Sep2021): Follow-up attempts are completed. No further information is expected.
Sex: F
Vaccine: COVID19
Symptoms: Psoriasis
Clinical narrative: PsO reappear on her scalp; This is a spontaneous report from a contactable consumer (patient). A 36-year-old female patient received BNT162B2 (PFIZER-BIONTECH COVID-19 VACCINE, Formulation: Solution for injection, Batch/Lot number was not reported) via an unspecified route of administration on an unspecified date as dose 1, single for COVID-19 immunisation. The patient medical history and concomitant medications were not reported. The patient experienced pso reappear on her scalp on an unspecified date. Outcome of the event was unknown.  The lot number for BNT162b2 was not provided and will be requested during follow up.
Sex: U
Vaccine: COVID19
Symptoms: Swelling
Clinical narrative: Very swollen on the side of chest; This is a spontaneous report from a contactable consumer or other non-health care professional (patient). A patient of unspecified age and gender received bnt162b2 (PFIZER-BIONTECH COVID-19 mRNA VACCINE, Formulation: Solution for injection, Batch/Lot number was not reported, NDC number, UPC number and Expiry Date are Unknown), via an unspecified route of administration on an unspecified date as dose number unknown, single for covid-19 immunisation.  The patient's medical history and concomitant medications were not reported.  On an unspecified date, the patient experienced very swollen on the side of chest. The clinical course was reported as follows: patient got the shot and there was action of about the shot today on the go very swollen on the side of the chest. The reporter needed to find out what is going on and asked if the patient has to go to the doctor or what to do? The reporter stated, "Okay, so what about an emergency as you said you can't answer the medical question about that situation so, Is it not 24 hours service? So, there is nobody can answer the question a doctor or general doctor practitioner." Reporter seriousness for very swollen on the side of chest was unspecified. The outcome of event was unknown.  Follow-up attempts have been completed. Batch/lot number is not available for [BNT162B2]. No further Information is expected.
Sex: U
Vaccine: COVID19
Symptoms: Erythema
Clinical narrative: Just a little red/ it is redness; This is a spontaneous report from a contactable consumer(patient). A patient of unspecified age and gender received second dose of BNT162B2 (BNT162B2, Solution for injection, Batch/Lot number was not reported), via an unspecified route of administration on 03Sep2021 as DOSE 2, SINGLE for covid-19 immunisation. The patient previously received first dose of bnt162b2 (BNT162B2, Solution for injection, Batch/Lot number was not reported), via an unspecified route of administration on an unspecified date as DOSE 1, SINGLE for covid-19 immunisation and experienced just the lot of itchiness and a rash on my body. The patient medical history and concomitant medications were not reported. The patient experienced just a little red/ it is redness on an unspecified date in 2021. The patient stated that, I took the last dosage, the last shot of the vaccine this morning. The only question was, was there any side effect, if I was to drink one Beer or two Beers in the evening. I am just a little, well I am just a little red but, I had came out of shower so I think it was just because of that but it was redness, there was swallowing in the face, (I know these were some of side effects, General statement hence event was not made). The patient was just curious just about the alcohol beverages. The outcome of the event was not recovered at the time of this report.   Follow-up attempts completed. Batch/lot number not available for [vaccine/BNT162B2]. No further information expected.